The results from NIHI’s ASCEND study, a world-first randomised controlled trial on e-cigarettes for smoking cessation, has been published in the world’s leading medical journal, The Lancet.
The research was led by NIHI director Dr Chris Bullen, and co-authored by NIHI’s Dr Colin Howe, Varsha Parag and Dr Natalie Walker; Dr Murray Laugesen of Health New Zealand; Dr Hayden McRobbie of the Institute of Preventive Medicine, UK Centre for Tobacco Control Studies, Queen Mary University of London; and Dr Jonathan Williman of the University of Otago.
The results were also presented at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, Spain on Sunday, 9 September 2013.
The Lancet article can be downloaded here: http://download.thelancet.com/flatcontentassets/pdfs/S0140673613618425.pdf
For more information about the ASCEND study and results visit: